Therapeutic strategies in multiple sclerosis. I. Immunotherapy.
This review first addresses several general aspects of the immunotherapy of multiple sclerosis. Next, two approved immunomodulatory treatments, interferon-beta and copolymer-1 (glatiramer acetate), are reviewed in more detail. Finally, other immunosuppressive therapies and experimental strategies are briefly discussed.
Hohlfeld
R
R
Institute for Clinical Neuroimmunology, Klinikum Grosshadern, University of Munich, Germany. hohlfeld@neuro.mpg.de
D020755:Coat Protein Complex I / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000628:therapy*
D020755:Coat Protein Complex I; D007166:Immunosuppressive Agents; D007372:Interferons